Td Asset Management Inc Abcam PLC Transaction History

Td Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$12.62 - $24.47 $6,183 - $11,990	490 Added 0.23%	210,085 $5.14 Million
Q1 2023 May 10, 2023	BUY	$12.98 - $17.1 $121,116 - $159,560	9,331 Added 4.66%	209,595 $2.82 Million
Q4 2022 Feb 06, 2023	BUY	$13.92 - $17.0 $733,932 - $896,325	52,725 Added 35.74%	200,264 $3.12 Million
Q3 2022 Nov 07, 2022	BUY	$13.36 - $16.75 $1.11 Million - $1.39 Million	83,109 Added 128.99%	147,539 $2.16 Million
Q2 2022 Aug 04, 2022	BUY	$12.69 - $19.25 $74,680 - $113,286	5,885 Added 10.05%	64,430 $932,000
Q1 2022 May 10, 2022	SELL	$15.5 - $23.89 $220,534 - $339,906	-14,228 Reduced 19.55%	58,545 $1.07 Million
Q4 2021 Feb 10, 2022	BUY	$20.04 - $23.84 $563,725 - $670,619	28,130 Added 63.01%	72,773 $1.71 Million
Q3 2021 Nov 09, 2021	BUY	$17.38 - $21.54 $1,981 - $2,455	114 Added 0.26%	44,643 $905,000
Q2 2021 Aug 11, 2021	BUY	$18.47 - $22.11 $166,876 - $199,763	9,035 Added 25.46%	44,529 $842,000
Q1 2021 May 14, 2021	BUY	$19.22 - $24.3 $147,782 - $186,842	7,689 Added 27.65%	35,494 $682,000
Q4 2020 Feb 16, 2021	BUY	$18.2 - $22.45 $506,051 - $624,222	27,805 New	27,805 $599,000

1.03M

Ticker ABCM
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 229,044,992
Description
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.